Plaintiffs and defendants in Similac recall lawsuits over contaminated infant formula have agreed upon a plan which would lead to as many as five early bellwether trials.
Tag Archives: Gastrointenstinal
An ingredient in the artificial sweetener Splenda may damage DNA and cause intestinal inflammation, according to a new study.
Similac Recall Class Action Lawsuits Dismissed By Federal Judge, But Individual Injury Claims Allowed to Proceed
A federal judge has dismissed all Similac recall class action lawsuits, while allowing individual injury claims to proceed.
Epidemiologists Weigh Adding Cronobacter to Disease Watch List Following Similac Infant Formula Recall
A group of state health care experts is expected to advise the CDC to add cronobacter to a national disease watch list which would require all incidents of the disease…
A CDC study calls for safer storage and preparation of infant formula products and breast pumps due to the increasing risk of cronobacter infections, such as those linked to a…
In Wake of Similac Recall, FDA Announces Strategy to Keep Cronobacter Out of Infant Formula Products
The FDA has introduced a new strategy outlining how the agency hopes to prevent cronobacter infant infections like those linked to a recent Similac recall.
After Similac Recall, FDA Advisory Committee Meeting on Cronobacter in Infant Formula Set for November
An FDA advisory committee will meet next month to discuss prevention of cronobacter and other safety issues linked to powdered infant formula following a massive Similac recall.
Parties involved in Similac, Alimentum and EleCare recall lawsuits will meet in October in a status conference to discuss how to proceed with a pending motion to dismiss the individual…
An internal FDA review highlights a number of shortcomings the agency needs to address in order to prevent mishandling public health emergencies like the contaminated Similac recall in the future.
Infant Formula Lawyers Appointed to Leadership Positions for MDL Over Recalled Similac, Alimentum and EleCare
A dozen lawyers have been appointed to leadership positions in the growing litigation over recalled Abbott infant formula products.
More Top Stories
The FDA is requiring new label warnings to alert patients and doctors to the risk of Ozempic intestinal blockage side effects.
Eight women have filed Uber sexual assault lawsuits, claiming the rideshare service failed to protect them from predatory drivers due to its lack of safety measures.
A new report highlights how many women and families feel left out of Camp Lejeune settlement negotiations after suffering repeated miscarriages they say were caused by miscarriages on the North Carolina military base.